Drug Shortage Report for LANSOPRAZOLE
Report ID | 90467 |
Drug Identification Number | 02433028 |
Brand name | LANSOPRAZOLE |
Common or Proper name | LANZOPRAZOLE |
Company Name | PHARMASCIENCE INC |
Market Status | DORMANT |
Active Ingredient(s) | LANSOPRAZOLE |
Strength(s) | 30MG |
Dosage form(s) | CAPSULE (DELAYED RELEASE) |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | A02BC |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2019-08-01 |
Actual start date | 2019-09-09 |
Estimated end date | 2020-07-10 |
Actual end date | 2020-06-09 |
Shortage status | Resolved |
Updated date | 2020-06-10 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v13 | 2020-06-10 | French | Compare |
v12 | 2020-06-10 | English | Compare |
v11 | 2020-03-10 | French | Compare |
v10 | 2020-03-10 | English | Compare |
v9 | 2019-12-24 | French | Compare |
v8 | 2019-12-24 | English | Compare |
v7 | 2019-11-15 | French | Compare |
v6 | 2019-11-15 | English | Compare |
v5 | 2019-09-12 | French | Compare |
v4 | 2019-09-12 | English | Compare |
v3 | 2019-08-02 | English | Compare |
v2 | 2019-07-31 | French | Compare |
v1 | 2019-07-31 | English | Compare |
Showing 1 to 13 of 13